UC San Diego AntiViral Research Center HQ

UC San Diego AntiViral Research Center HQ The AVRC HQ provides access to confidential and innovative HIV clinical trials and testing for peopl
(18)

The UC San Diego AntiViral Research Center (AVRC HQ) develops and conducts innovative research that enhances the quality and duration of life for people living with HIV and other infections of global significance. The award-winning research center is an established leader in San Diego’s HIV research community and is well known for its HIV testing programs. Internationally, the AVRC extends its research and education programs to Africa, Asia, and South America.

Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct...
09/19/2024

Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an investigator-initiated trial to evaluate the efficacy of Xafty®, a niclosamide-based antiviral developed by its Korean headquarters, in treating "Long-COVID". The trial will be led by UCSD Professor Ajay Bharti, an infectious disease specialist and clinical trialist. Dr. Bharti's particular expertise in the neurocognitive effects of viral illnesses make him perfectly suited to run the investigator-initiated trial.

/PRNewswire/ -- Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an...

NIAID-supported Clinical Studies Assess Therapeutics for Clearance of HIV from the Reservoir.
08/08/2024

NIAID-supported Clinical Studies Assess Therapeutics for Clearance of HIV from the Reservoir.

Many promising HIV cure strategies use broadly neutralizing antibodies, or bNAbs, which can neutralize a wide range of HIV variants, homing in on and binding to specific viral components, and then acting to destroy the virus by triggering an immune response. Several HIV bNAbs have been developed and...

Our study with the City of Hope  and  Sanford Stem Cell Institute  represents one of the first attempts at applying grou...
08/08/2024

Our study with the City of Hope and Sanford Stem Cell Institute represents one of the first attempts at applying groundbreaking technology to HIV treatment.

Health HIV Cure Study at UCSD A Conversation with Dr. Davey Smith, MD July 31, 2024 thewordsd.news By Cesar A Reyes Human immunodeficiency virus type 1 (HIV-1) causes a persistent infection that ultimately leads to acquired immunodeficiency syndrome (AIDS). Treatment of HIV-1 infection with combinat...

Prehistoric cold viruses are hard to find in the historical record, but scientists have unearthed some evidence in ancie...
05/01/2024

Prehistoric cold viruses are hard to find in the historical record, but scientists have unearthed some evidence in ancient human teeth.

Features AVRC investigator Dr. Joel Wertheim.

Read more:

Prehistoric cold viruses are hard to find in the historical record, but scientists have unearthed some evidence in ancient human teeth.

To bolster Long COVID research efforts, NIH is investing an additional $515 million over the next four years into the Re...
02/13/2024

To bolster Long COVID research efforts, NIH is investing an additional $515 million over the next four years into the Researching COVID to Enhance Recovery (RECOVER) Initiative, a nationwide research program to fully understand, diagnose and treat Long COVID. Launched in 2021 with $1.15 billion in Congressional appropriations, the RECOVER Initiative is taking a systematic, comprehensive and rigorous approach to improve our understanding of Long COVID and increase the odds of identifying treatments that work.

Read more:

Infection-associated chronic conditions, such as Long COVID, have been notoriously difficult to solve.

Today is National Black HIV/AIDS Awareness Day. NIAID highlights ongoing efforts to reduce the burden of HIV among Black...
02/07/2024

Today is National Black HIV/AIDS Awareness Day. NIAID highlights ongoing efforts to reduce the burden of HIV among Black Americans while increasing the representation of Black communities and researchers in HIV science.

Read more:

Health inequities and disparities disproportionately affect Black people and other historically marginalized groups at above average rates. NIAID highlights ongoing efforts to reduce the burden of HIV among Black Americans while increasing the representation of Black communities and researchers in H...

Register by January 31, 2024 at poz@pozabilities.org or call/text 619-241-8538!
01/23/2024

Register by January 31, 2024 at [email protected] or call/text 619-241-8538!

01/17/2024

Findings support the HIV fusion peptide as a promising preventive vaccine target.

The article features AVRC researcher, Dr. Joel Wertheim!
01/16/2024

The article features AVRC researcher, Dr. Joel Wertheim!

Infection preventative measures, including high ventilation standards and universal masking, prevented many SARS-CoV-2 transmissions during the height of the COVID-19 pandemic, a UC San Diego-led study published Tuesday revealed.

01/12/2024

Common as they are, reinfections may have lasting impacts.

Every year on December 1st, the world unites to commemorate World AIDS Day. This annual event serves as a reminder of th...
12/01/2023

Every year on December 1st, the world unites to commemorate World AIDS Day. This annual event serves as a reminder of the global struggle to end HIV-related stigma, an opportunity to honor those we have lost, and a rallying cry to continue working toward a day when HIV is no longer a public health threat. In 2023, we mark the 35th commemoration of this important day with the theme “World AIDS Day 35: Remember and Commit”.

Read more at https://www.hiv.gov/blog/world-aids-day-35-remember-and-commit/

We are thrilled to be of service!
11/21/2023

We are thrilled to be of service!

Last Thursday, the incredible team from University of California San Diego (UCSD) Anti-Viral Research Center (AVRC) joined us at Mama's Kitchen to help pack 710 nutritious salads! 🥗

UCSD AVRC plays a pivotal role in developing and conducting innovative research to improve the quality of life for those affected by HIV. Their dedicated efforts in and out of work truly make a difference in our community.

Thanks for tossing in your support UCSD AVRC! 🌱

We are here at the Jackie Robinson Family YMCA from 10a-3pm for the monthly community health and resource fair, so come ...
10/04/2023

We are here at the Jackie Robinson Family YMCA from 10a-3pm for the monthly community health and resource fair, so come pay us a visit!

Check out our latest newsletter!
09/29/2023

Check out our latest newsletter!

October 15 is National Latinx AIDS Awareness Day (NLAAD), which was first observed in 2003 by the Hispanic Federation and the Latino Commission on AIDS.  NLAAD is an opportunity to help address the disproportionate impact of HIV on Hispanic/Latinx communities, promote HIV testing, and stop HIV s...

September 27 is National Gay Men’s HIV/AIDS Awareness Day, a day to help stop HIV stigma and encourage HIV testing, prev...
09/27/2023

September 27 is National Gay Men’s HIV/AIDS Awareness Day, a day to help stop HIV stigma and encourage HIV testing, prevention, and treatment among gay and bisexual men. Visit https://bit.ly/3Q7IqHD for more info.

September 18 is National HIV/AIDS & Aging Awareness Day, a day to combat stigma faced by older Americans with HIV and ad...
09/18/2023

September 18 is National HIV/AIDS & Aging Awareness Day, a day to combat stigma faced by older Americans with HIV and address aging-related challenges of HIV testing, prevention, and care. Visit https://bit.ly/3CeWcVd to learn more.

Several treatments are now being used for COVID-19. However, new treatment options are needed to help people recover fas...
09/11/2023

Several treatments are now being used for COVID-19. However, new treatment options are needed to help people recover faster from COVID-19. This is a clinical research study looking at whether an investigational drug for COVID-19 can help resolve COVID-19 symptoms faster in people who have tested positive.

Eligibility requirements include:
o Positive diagnosis of COVID-19 in the past 3 days
o Experiencing COVID-19 symptoms within the past 3 days
o Participants may be allowed to receive standard of care treatment for COVID-19 during the study, except for Paxlovid (nirmatrelvir/ritonavir) or other medications that can interact with the investigational drug
o Eight study visits over 24 weeks with compensation up to $1150

If interested in participating, contact Rose at (619) 543-5010 or [email protected].

Take the first step to staying healthy! On National   (annually on June 27), show yourself some love by finding out your...
06/27/2023

Take the first step to staying healthy! On National (annually on June 27), show yourself some love by finding out your HIV status. HIV self-tests give you the power to decide when and where to test.

VIDA distributes free HIV self-tests every Wednesday at MO's Bar and Grill from 5pm-8pm!

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against...
06/16/2023

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19. This type of decoy may be able to provide protection even as the SARS-CoV-2 virus continues to change over time.

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.

06/08/2023

In recent years, we’ve witnessed some truly inspiring progress in vaccine development. That includes the mRNA vaccines that were so critical during the COVID-19 pandemic, the first approved vaccine…

Address

220 Dickinson Street, Ste A
San Diego, CA
92103

Opening Hours

Monday 8am - 4:30pm
Tuesday 8am - 4:30pm
Wednesday 8am - 4:30pm
Thursday 8am - 4:30pm
Friday 8am - 4:30pm

Telephone

(619) 543-8080

Alerts

Be the first to know and let us send you an email when UC San Diego AntiViral Research Center HQ posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UC San Diego AntiViral Research Center HQ:

Videos

Share

Our Story

The AntiViral Research Center (AVRC) HQ develops and conducts innovative research that enhances the quality and duration of life for people living with HIV infection and other infections of global significance. The award-winning research center is an established leader in San Diego’s HIV research community and is well known for its HIV testing programs. Internationally, the AVRC extends its research and education programs to Africa, Asia, and South America.


Other Medical Research in San Diego

Show All